IL-32 Supports the Survival of Malignant T Cells in Cutaneous T-cell Lymphoma.

Kenneth K Yu Neal P Smith Sernah V Essien Jessica E Teague Pablo Vieyra-Garcia Ahmed Gehad Qian Zhan Jack D Crouch Nega Gerard Cecilia Larocca Peter Wolf Nicole R LeBoeuf Marianne Tawa Thomas S Kupper Alexandra-Chloé Villani Rachael A Clark

J Invest Dermatol

Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Center for Cutaneous Oncology, Dana-Farber Brigham Cancer Center, Harvard Medical School, Boston, Massachusetts, USA. Electronic address:

Published: August 2022

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329172	PMC
http://dx.doi.org/10.1016/j.jid.2022.01.009	DOI Listing

Publication Analysis

Top Keywords

il-32 supports

supports survival

survival malignant

malignant cells

cells cutaneous

cutaneous t-cell

t-cell lymphoma

il-32

survival

malignant

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!